MedTrace Logo

Blood Transfusion Risk Factors and Cell Saver Impact in Pediatric Scoliosis Surgery

NCT07661589 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-06-22

No results posted yet for this study

Summary

Spine surgery for scoliosis correction in pediatric patients is a major procedure associated with a high risk of perioperative blood loss. Homologous blood transfusion carries inherent risks, including immunological reactions, infections, and increased healthcare costs. Identifying high-risk patients is crucial to optimize blood conservation strategies. This retrospective study aims to identify preoperative and intraoperative risk factors associated with homologous red blood cell (RBC) transfusion and to evaluate the quantitative impact of Cell Saver volume reinfusion on reducing homologous transfusion requirements.

Conditions

  • Scoliosis; Spinal Fusion; Blood Transfusion; Operative Blood Loss

Interventions

PROCEDURE

posterior Instrumented Spinal Fusion

Standard surgical correction of scoliosis via a posterior approach with spinal instrumentation and arthrodesis, performed under general anesthesia

DEVICE

Intraoperative Cell Saver Autologous Reinfusion

Use of an intraoperative autologous blood salvage device (Cell Saver) during spine surgery. Collected blood is washed, filtered, and reinfused to the patient peroperatively to reduce the need for homologous blood transfusion.

Sponsors & Collaborators

  • Mehdi Trifa

    lead OTHER

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-03-02
Completion
2026-12-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07661589 on ClinicalTrials.gov